MARKSANS PHARMA
|
MARKSANS PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹561 Cr | ₹504 Cr | ₹424 Cr | ₹338 Cr | ₹248 Cr |
| Adjustment | ₹100 Cr | ₹69 Cr | ₹55 Cr | ₹74 Cr | ₹35 Cr |
| Changes In working Capital | ₹-62 Cr | ₹-241 Cr | ₹-126 Cr | ₹-111 Cr | ₹-111 Cr |
| Cash Flow after changes in Working Capital | ₹598 Cr | ₹333 Cr | ₹353 Cr | ₹300 Cr | ₹172 Cr |
| Cash Flow from Operating Activities | ₹458 Cr | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr |
| Cash Flow from Investing Activities | ₹-248 Cr | ₹-49 Cr | ₹-141 Cr | ₹-259 Cr | ₹-84 Cr |
| Cash Flow from Financing Activities | ₹-71 Cr | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr |
| Net Cash Inflow / Outflow | ₹139 Cr | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr |
| Opening Cash & Cash Equivalents | ₹496 Cr | ₹403 Cr | ₹382 Cr | ₹206 Cr | ₹112 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-0.58 Cr | - | - | ₹0.00 Cr | - |
| Closing Cash & Cash Equivalent | ₹634 Cr | ₹496 Cr | ₹403 Cr | ₹382 Cr | ₹206 Cr |
Compare Cashflow Statement of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,158.0 Cr | 4.2% | -3.1% | 72.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 4.2% |
-3.1% |
72.3% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses